Health
mend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs"). Referred to the House Committee on Energy and Commerce. Health
To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs"). Referred to the House Committee on Energy and Commerce. He
![Rep. Bilirakis, Gus M. [R-FL-12]](https://www.congress.gov/img/member/117_rp_fl_12_bilirakis_gus_200.jpg)